Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gemcitabine (gemzar) (1 trial)
mgi-114 (1 trial)
n-(4-hydroxyphenyl)all-trans retinamide (1 trial)
triapine (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Stomach Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (4 total)